Healthcare ETF (IYH) Hits New 52-Week High

IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.

Zacks Investment Research • Nov 25, 2025

Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH

The Investment Committee give you their top stocks to watch for the second half.

CNBC Television • Nov 17, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs

Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.

Zacks Investment Research • Oct 24, 2025

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

Zacks Investment Research • Oct 16, 2025

IYH: Healthcare Dashboard For September

This article provides a top-down view of the healthcare sector based on fundamental metrics. Healthcare providers and pharmaceutical/biotechnology subsectors are undervalued versus 11-year averages. Fast facts on iShares U.S. Healthcare ETF, an alternative to XLV.

Seeking Alpha • Sep 17, 2025

As the Market Rotates, This Healthcare ETF Is Leading the Way

Over the past month, the market has undergone a rotation that's seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market's footing.

MarketBeat • Aug 26, 2025

IYH: An Aggressive Positioning On The U.S. Healthcare Industry

IYH is a buy for bullish investors in U.S. healthcare, offering strong exposure to industry leaders benefiting from innovation, aging populations, and digital transformation. The ETF's concentrated portfolio targets pharmaceuticals, equipment, and biotechnology, positioning it to capitalize on key market growth trends and outperform peers if the sector thrives. IYH boasts the lowest expense ratio among peers and has outperformed over 5 years, but its high concentration increases risk compared to more diversified alternatives like VHT.

Seeking Alpha • Jul 14, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

IYH: Healthcare Dashboard For April

This article provides a top-down analysis of the healthcare sector, focusing on value, quality and momentum metrics. Current data shows no healthcare subsector is particularly attractive; the least compelling one is pharmaceuticals/biotechnology, with both value and quality scores significantly below the baseline. iShares U.S. Healthcare ETF (IYH) has little to show compared to Health Care Select Sector SPDR ETF (XLV), which offers a better historical return, lower expense ratio, and higher liquidity.

Seeking Alpha • Apr 16, 2025